152 related articles for article (PubMed ID: 37252237)
1. Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma.
Lu T; Shi X; Ge X; Li Y; Cai Y; Chen X; Hu S; Ding M; Fang X; Liu F; Zhou X; Wang X
Front Nutr; 2023; 10():1080181. PubMed ID: 37252237
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.
Zhang S; Sun C; Chen X; Li D; Hu L; Zhang M; Zhang X; Zhang H; Ye J; Wang L; Jia T; Zhu T; Miao Y; Wang C; Wang L; Yan D; Shen Z; Sang W
Ann Hematol; 2023 Jun; 102(6):1433-1442. PubMed ID: 37074377
[TBL] [Abstract][Full Text] [Related]
3. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
Wu W; Ren K; Chen X; Li N; Zhou H; Jiang M; Yu Y; Zou L
Cancer Med; 2023 Apr; 12(8):9439-9448. PubMed ID: 36866811
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma.
Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W
Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135
[TBL] [Abstract][Full Text] [Related]
5. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Jiang M; Wu WC; Zou LQ
Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
[TBL] [Abstract][Full Text] [Related]
6. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK.
Kang S; Cho H; Kim S; Lee K; Kang EH; Park JS; Lee YS; Park CS; Go H; Huh J; Ryu JS; Lee SW; Kim SJ; Kim WS; Yoon SE; Ko YH; Suh C
Cancer Res Treat; 2023 Jan; 55(1):314-324. PubMed ID: 35381163
[TBL] [Abstract][Full Text] [Related]
7. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
8. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J
Front Oncol; 2020; 10():877. PubMed ID: 32637354
[No Abstract] [Full Text] [Related]
10. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
Zhang Y; Kong FF; Zhu ZQ; Shan HX
BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma.
Liu T; Hu R; Lv J; Luo Q; Xu L; Wang C; Liu J; Yang Z; Xu L; Liu Y
Front Nutr; 2022; 9():1050139. PubMed ID: 36438738
[TBL] [Abstract][Full Text] [Related]
12. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease.
Lim SH; Hong JY; Lim ST; Hong H; Arnoud J; Zhao W; Yoon DH; Tang T; Cho J; Park S; Ko YH; Kim SJ; Suh C; Lin T; Kim WS
Ann Oncol; 2017 Sep; 28(9):2199-2205. PubMed ID: 28911074
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
Li J; Li J; Zhong M; Zhou H; Yu B
Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
[TBL] [Abstract][Full Text] [Related]
14. Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas.
Lu T; Shi L; Shi G; Cai Y; Hu S; Liu J; Ren S; Zhou X; Wang X
Cancer Cell Int; 2021 Jul; 21(1):348. PubMed ID: 34225710
[TBL] [Abstract][Full Text] [Related]
15. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
16. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme.
Yılmaz H; Niğdelioğlu B; Oktay E; Meydan N
J Clin Neurosci; 2021 Apr; 86():260-266. PubMed ID: 33775339
[TBL] [Abstract][Full Text] [Related]
18. The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients.
Baysal M; Bas V; Demirci U; Gulsaran SK; Umit E; Kirkizlar HO; Demir AM
Niger J Clin Pract; 2021 Aug; 24(8):1194-1199. PubMed ID: 34397030
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.
Suzuki H; Ito M; Takemura K; Nakanishi Y; Kataoka M; Sakamoto K; Tobisu KI; Koga F
Urol Oncol; 2020 Mar; 38(3):76.e11-76.e17. PubMed ID: 31864938
[TBL] [Abstract][Full Text] [Related]
20. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]